FDA Inspection
Stat Rx USAStat Rx USA – FDA Inspection, Feb 15, 2012
Record Details
This FDA Inspection record concerns Stat Rx USA, with an inspection on February 15, 2012, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Stat Rx USA
- Inspection Date
- February 15, 2012
- Product Type
- Drugs
View Company Profile
ID · 56d9850b-b964-487e-850d-0b04dbe25e97
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 769956
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
11- 21 CFR 211.170(a)Active ingredient retained sample kept
- 21 CFR 211.188(b)(9)Description of containers and closures
- 21 CFR 211.192Quality control unit review of records
- 21 CFR 211.142(a)Quarantine - actual practice
- 21 CFR 211.84(a)Components withheld from use pending release
- 21 CFR 211.46(b)Equipment for Environmental Control
- 21 CFR 211.204Returned drug procedures in writing and followed
- 21 CFR 211.204Returned drug products with doubt cast as to safety et. al.
- 21 CFR 211.105(b)Distinctive ID or code not recorded in batch record
- 21 CFR 211.182Personnel dating/signing equipment log
Showing 10 of 11 citations.
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Stat Rx USA
1| Date | Classification | Office | Project area |
|---|---|---|---|
| April 29, 2009 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Stat Rx USA
- FDA Inspection 579389 - 2009-04-29
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.